B cells and aging: molecules and mechanisms
- PMID: 19540810
- PMCID: PMC2766868
- DOI: 10.1016/j.it.2009.04.005
B cells and aging: molecules and mechanisms
Abstract
Recent advances allow aging-associated changes in B-cell function to be approached at a mechanistic level. Reduced expression of genes crucial to lineage commitment and differentiation yield diminished B-cell production. Moreover, intrinsic differences in the repertoire generated by B-cell precursors in aged individuals, coupled with falling B-cell generation rates and life-long homeostatic competition, result in narrowed clonotypic diversity. Similarly, reductions in gene products crucial for immunoglobulin class switch recombination and somatic hypermutation impact the efficacy of humoral immune responses. Together, these findings set the stage for integrated analyses of how age-related changes at the molecular, cellular and population levels interact to yield the overall aging phenotype.
Figures
References
-
- Ben-Yehuda A, Weksler ME. Immune senescence: mechanisms and clinical implications. Cancer Invest. 1992;10:525–531. - PubMed
-
- Miller RA. The aging immune system: primer and prospectus. Science. 1996;273:70–74. - PubMed
-
- Franceschi C, et al. Immunosenescence. Aging (Milano) 1998;10:153–154. - PubMed
-
- Malaguarnera L, et al. Immunosenescence: a review. Arch Gerontol Geriatr. 2001;32:1–14. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
